A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: Final report

Giancarlo A. Pillot, William L. Read, Kristin L. Hennenfent, Sharon Marsh, Feng Gao, Avinash Viswanathan, Kristopher Cummings, Howard L. McLeod, Ramaswamy Govindan

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: Final report'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science